Abstract Predicting outcomes in individuals at clinical high risk (CHR) of developing psychosis remains challenging using clinical metrics alone. The…
Abstract Background: The association between cannabis and psychosis is established, but the role of underlying genetics is unclear. We used…
Abstract The rising prevalence and legalisation of cannabis worldwide have underscored the need for a comprehensive understanding of its biological…
Abstract Background: Interactions between the endocannabinoid system (ECS) and neurotransmitter systems might mediate the risk of developing a schizophrenia spectrum…
Abstract Background and Hypothesis: Recent findings suggest the incidence of first-episode psychotic disorders (FEP) varies according to setting-level deprivation and…
Abstract Background: While cannabis use is a well-established risk factor for psychosis, little is known about any association between reasons…
Abstract Background: Childhood adversity and cannabis use are considered independent risk factors for psychosis, but whether different patterns of cannabis…
Abstract Aims: Evidence for case–control studies suggests that cannabis use is a risk factor for the development of psychosis. However,…
Abstract Background: Daily use of high-potency cannabis has been reported to carry a high risk for developing a psychotic disorder.…
Abstract Background: Cannabis use is associated with increased risk of later psychotic disorder but whether it affects incidence of the…